EGFR and lung carcinoma: In conclusion, this study has provided evidence of the clinical validity and utility of a RT-PCR and a MS test for the detection of EGFR gene mutations that predict the prognosis and clinical benefits of EGFR-TKI treatment in lung cancer patients.